TABLE 1.

Correlations between IA/IgG immunotherapy and clinical features of DCM in male and female patients.

Clinical Characteristics	Baseline	Follow up	p value
Male patients	—	—	—
LVEF (%)	34.70 ± 5.43	43.22 ± 8.88	3.74E-04
LVIDD (%)	70.74 ± 6.72	65.70 ± 10.30	1.417E-04
Inflammation index (CD68+ + CD3+) %	21.26 ± 12.17	17.87 ± 8.88	0.271
Female patients	—	—	—
LVEF (%)	32.00 ± 7.44	40.00 ± 7.93	0.002
LVIDD (%)	67.20 ± 9.40	64.40 ± 9.79	0.047
Inflammation index (cd68+ + cd3+) %	16.80 ± 5.55	13.70 ± 7.66	0.132

Bold values indicate p < 0.05.